Cargando…
Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global threat. To forestall the pandemic, developing safe and effective vaccines is necessary. Because of the rapid production and little effect on the host genome,...
Autores principales: | Nakamura, Akina, Kotaki, Tomohiro, Nagai, Yurie, Takazawa, Shunta, Tokunaga, Kenzo, Kameoka, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584447/ https://www.ncbi.nlm.nih.gov/pubmed/36264936 http://dx.doi.org/10.1371/journal.pone.0274829 |
Ejemplares similares
-
Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities
por: Takazawa, Shunta, et al.
Publicado: (2023) -
A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
por: Kotaki, Tomohiro, et al.
Publicado: (2021) -
Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection
por: Kotaki, Tomohiro, et al.
Publicado: (2022) -
CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures
por: Ophinni, Youdiil, et al.
Publicado: (2018) -
A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses
por: Oreshkova, Nadia, et al.
Publicado: (2021)